Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts.
about
Induced pluripotent stem cell-derived vascular smooth muscle cells: methods and applicationTissue engineering in the vasculatureNon-invasive and Non-destructive Characterization of Tissue Engineered Constructs Using Ultrasound Imaging Technologies: A Review.Generation and grafting of tissue-engineered vessels in a mouse modelThe Tissue-Engineered Vascular Graft-Past, Present, and Future.Imaging challenges in biomaterials and tissue engineering.Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical applicationFibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies.Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction.iPS cell sheets created by a novel magnetite tissue engineering method for reparative angiogenesisChallenges in translating vascular tissue engineering to the pediatric clinic.The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine.Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease.Application of the cell sheet technique in tissue engineering.Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells.Preclinical studies for induced pluripotent stem cell-based therapeuticsCompared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration.Arterial tissue regeneration for pediatric applications: inspiration from up-to-date tissue-engineered vascular bypass grafts.Vascular tissue engineering: from in vitro to in situ.Tissue engineering vascular grafts a fortiori: looking back and going forward.Natural and Synthetic Materials for Self-Renewal, Long-Term Maintenance, and Differentiation of Induced Pluripotent Stem Cells.Stem Cells on Biomaterials for Synthetic Grafts to Promote Vascular Healing.Stem cell-derived vasculature: A potent and multidimensional technology for basic research, disease modeling, and tissue engineering.Cell-based strategies for vascular regeneration.Stem cell-derived cell-sheets for connective tissue engineering.Tissue engineered vascular grafts: current state of the field.Endothelial lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor β2 (TGF-β2) pathways.Reprogramming approaches in cardiovascular regeneration.Human Corneal Endothelial Cell Cultivation From Old Donor Corneas With Forced Attachment.Human Pluripotent Stem Cells to Engineer Blood Vessels.Transplantation of artificial human lymphatic vascular tissues fabricated using a cell-accumulation technique and their engraftment in mouse tissue with vascular remodelling.Human induced pluripotent stem cell-derived vascular smooth muscle cells: differentiation and therapeutic potential.Transplantation of three-dimensional artificial human vascular tissues fabricated using an extracellular matrix nanofilm-based cell-accumulation technique.Biomaterials and heart recovery: cardiac repair, regeneration and healing in the MCS era: a state of the "heart"In Vivo Performance of Decellularized Vascular Grafts: A Review Article
P2860
Q26853054-CC4F9C28-6E75-4AF0-A18E-01637A271122Q26999017-8D13C9BE-877E-4D75-B449-73906B9A4811Q30362064-5051986B-49BD-41F7-BA6B-4C55B0E766C8Q30373624-D66DB2E2-521C-4AE7-A525-B5F439910E84Q30385854-5FFFF5EE-1DC8-4627-A995-EF4A9FF5D69FQ30431707-9AEDDEC0-F0F4-48A5-85B2-0991875B31A4Q33651561-5EB1C755-0668-4CD5-83BB-BBE84A391915Q34145642-186F3C04-2BCF-4E97-BB58-FB90C248544DQ34527004-B9DF9BE5-1DB9-4C98-A4F3-CC078873DCE1Q34615703-21518602-1F5C-4D52-8D3F-0470D3A5CC18Q35486978-59DD3594-70A1-44CF-9975-92CDF3B8730EQ35765543-657D7FF2-166C-48EF-9286-0EBDF196709BQ36033594-B54D318E-17DF-4972-90C0-91AF71F16861Q36321381-34FC58E3-C35A-4BF9-943D-847FFEA8AC5CQ37055304-38301F05-550C-461B-A951-2B90DA6E71ABQ37596291-D264F91F-4EE3-4595-928D-CF3295793741Q37713328-0B55C37E-30F6-4DDA-BE20-113C491DAC52Q38095588-40A72DDB-F4DE-4D31-817D-97D911447695Q38154848-2EDCCFB1-EE6F-44E7-B13E-E286187D1C59Q38271812-633BB0B0-2F27-46CF-8714-C6FFCB13209DQ38418144-8D8D760C-D75C-4467-B30A-BB542A751560Q38559646-B89352CB-D954-4218-A6EB-A9BAF7A26E10Q38597068-1805CAC0-AA86-4CC8-842E-2124F91F0899Q38728774-F88CE3C7-4A59-41B4-8D2A-E6713820778EQ38799501-6CCB1635-264B-4CDE-A454-523B3CDBF4E0Q38817609-A1508D3D-23DE-437F-890B-2EBFC66199B4Q39041655-ED2C6DC9-A4E3-48D8-AFF8-1D26745DBF37Q39176130-C684418B-3B8E-47E1-AAA0-D4DDF63060B8Q42274005-9B1F6CE1-5581-4842-8C51-BF4D599EF140Q47393306-E242902C-6B5B-4839-A272-231967BE5042Q47712123-3ECA5D6A-E7CB-4A5C-8695-4B8E5D1D8912Q50243876-C38A2618-EFE9-41F1-9F95-13D0A921ECA6Q51647272-D5B3BD32-7C51-4007-B018-6BCA586B44D2Q56376510-A19E5185-AF09-4A14-B03D-D67EF57DD498Q57175348-790DC5C5-85EA-4725-A860-B9E06EF033A0
P2860
Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Evaluation of the use of an in ...... ue-engineered vascular grafts.
@ast
Evaluation of the use of an in ...... ue-engineered vascular grafts.
@en
type
label
Evaluation of the use of an in ...... ue-engineered vascular grafts.
@ast
Evaluation of the use of an in ...... ue-engineered vascular grafts.
@en
prefLabel
Evaluation of the use of an in ...... ue-engineered vascular grafts.
@ast
Evaluation of the use of an in ...... ue-engineered vascular grafts.
@en
P2093
P2860
P1476
Evaluation of the use of an in ...... ue-engineered vascular grafts.
@en
P2093
Ani Nalbandian
Narutoshi Hibino
Toshiharu Shinoka
Yibing Qyang
P2860
P304
P356
10.1016/J.JTCVS.2011.06.046
P407
P577
2012-01-12T00:00:00Z